Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,350 | 55,633 | 136,280 | 47,831 | 25,738 |
| Marketable Securities | 19,893 | 18,473 | 18,995 | 113,839 | 113,931 |
| Receivables | 53,530 | 42,780 | 33,880 | 20,188 | 33,204 |
| Inventories | 61,578 | 61,781 | 43,301 | 43,150 | 44,179 |
| Income taxes - deferred | 12,215 | N/A | N/A | N/A | N/A |
| Other current assets | 2,308 | 2,156 | 2,716 | 3,430 | 3,385 |
| TOTAL | $205,538 | $186,383 | $239,770 | $233,298 | $227,052 |
| Non-Current Assets | |||||
| PPE Net | 69,784 | 71,153 | 56,859 | 56,887 | 56,693 |
| Investments And Advances | 5,424 | 4,539 | 4,539 | 3,802 | 2,344 |
| Intangibles | 85,154 | 93,730 | 15,088 | 14,198 | 15,043 |
| Other Non-Current Assets | 13,326 | 24,153 | 309 | 258 | 282 |
| TOTAL | $173,688 | $193,575 | $76,795 | $75,145 | $74,362 |
| Total Assets | $379,226 | $379,958 | $316,565 | $308,443 | $301,414 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 275 | 508 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 46,582 | 32,710 | 27,314 | 21,429 | 21,835 |
| Accrued Expenses | 26,694 | 30,030 | 21,368 | 20,347 | 19,793 |
| Other current liabilities | 10,730 | 8,079 | 7,528 | 6,010 | 3,790 |
| TOTAL | $93,106 | $85,551 | $64,834 | $51,245 | $48,838 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,702 | 1,945 | N/A | N/A | N/A |
| Deferred Revenues | 8,825 | 8,725 | 8,624 | 3,459 | 3,420 |
| Other Non-Current Liabilities | 2,489 | 2,954 | 1,981 | 2,051 | 2,080 |
| TOTAL | $18,014 | $20,605 | $1,981 | $10,574 | $10,505 |
| Total Liabilities | $111,120 | $106,156 | $66,815 | $61,819 | $59,343 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,089 | 32,080 | 31,910 | 31,897 | 31,865 |
| Common Shares | 321 | 320 | 319 | 319 | 319 |
| Retained earnings | -76,069 | -77,106 | -103,944 | -105,869 | -108,938 |
| Other shareholders' equity | -10,382 | -3,374 | 17 | 120 | 66 |
| TOTAL | $268,106 | $273,802 | $249,750 | $246,624 | $242,071 |
| Total Liabilities And Equity | $379,226 | $379,958 | $316,565 | $308,443 | $301,414 |